Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report
Masayasu Urushibara; Kazuhiro Ishizaka; Noriyuki Matsutani; Mikiko Takahashi; Masakazu Nagata; Taisuke Okumura; Yuuki Matsumoto; Shinichiro Tatsuoka; Tsunehiro Nenohi; Takumasa Amemiya; Yohei Shimizu; Takeshi Shirakawa; Daisuke Kato
World Journal of Surgical Oncology 2023年02月
[査読有り]